Gastric cancer stem cells survive in stress environments via their autophagy system.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 10 2021
Historique:
received: 16 11 2020
accepted: 30 09 2021
entrez: 20 10 2021
pubmed: 21 10 2021
medline: 27 1 2022
Statut: epublish

Résumé

Cancer stem cells (CSCs) play an important role in the progression of carcinoma and have a high potential for survival in stress environments. However, the mechanisms of survival potential of CSCs have been unclear. The aim of this study was to clarify the significance of autophagy systems of CSCs under stress environments. Four gastric cancer cell line were used. Side population (SP) cells were sorted from the parent cells, as CSC rich cells. The expression of stem cell markers was examined by RT-PCR. The viability of cancer cells under starvation and hypoxia was evaluated. The expression level of the autophagy molecule LC3B-II was examined by western blot. The numbers of autophagosomes and autolysosomes were counted by electron microscope. SP cells of OCUM-12 showed a higher expression of stem cell markers and higher viability in starvation and hypoxia. Western blot and electron microscope examinations indicated that the autophagy was more induced in SP cells than in parent cells. The autophagy inhibitor significantly decreased the viability under the stress environments. These findings suggested that Cancer stem cells of gastric cancer might maintain their viability via the autophagy system. Autophagy inhibitors might be a promising therapeutic agent for gastric cancer.

Identifiants

pubmed: 34667215
doi: 10.1038/s41598-021-00155-3
pii: 10.1038/s41598-021-00155-3
pmc: PMC8526688
doi:

Substances chimiques

Biomarkers, Tumor 0
Microtubule-Associated Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20664

Informations de copyright

© 2021. The Author(s).

Références

Acta Pathol Jpn. 1986 Jan;36(1):65-83
pubmed: 3962675
Cell Cycle. 2007 Oct 15;6(20):2554-62
pubmed: 17912032
Am J Pathol. 2011 Apr;178(4):1792-804
pubmed: 21435459
Int J Cancer. 2014 Apr 15;134(8):1785-95
pubmed: 24155219
Cancer Res. 2007 Oct 15;67(20):9677-84
pubmed: 17942897
Cell Metab. 2017 May 2;25(5):1037-1043
pubmed: 28467923
Cell. 2011 Nov 11;147(4):728-41
pubmed: 22078875
Cancer Lett. 2013 Oct 1;339(1):70-81
pubmed: 23879969
Cancer Lett. 2014 Mar 28;344(2):180-7
pubmed: 24333726
Autophagy. 2007 Nov-Dec;3(6):542-5
pubmed: 17611390
Cell Death Dis. 2015 Jul 02;6:e1805
pubmed: 26136078
Cell Death Differ. 2019 Mar;26(4):690-702
pubmed: 30728463
Cell. 2007 May 4;129(3):465-72
pubmed: 17482542
Int J Mol Sci. 2017 Feb 10;18(2):
pubmed: 28208579
J Biol Chem. 2004 Jun 4;279(23):24218-25
pubmed: 15044468
World J Stem Cells. 2019 Jul 26;11(7):398-420
pubmed: 31396368
Clin Exp Metastasis. 1996 Jan;14(1):43-54
pubmed: 8521616
Oncotarget. 2015 Dec 29;6(42):44191-206
pubmed: 26496035
Clin Exp Dent Res. 2019 Jun 25;5(4):389-397
pubmed: 31452949
Int J Oncol. 2009 May;34(5):1201-7
pubmed: 19360333
Br J Cancer. 2010 Mar 2;102(5):898-907
pubmed: 20145613
Cell Death Dis. 2017 Jul 20;8(7):e2943
pubmed: 28726781
Eur J Histochem. 2015 May 05;59(2):2481
pubmed: 26150155
PLoS Pathog. 2021 Mar 4;17(3):e1009320
pubmed: 33662035
Cancer Sci. 2009 Aug;100(8):1397-402
pubmed: 19493275

Auteurs

Shingo Togano (S)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Masakazu Yashiro (M)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan. m9312510@med.osaka-cu.ac.jp.
Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan. m9312510@med.osaka-cu.ac.jp.
Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan. m9312510@med.osaka-cu.ac.jp.

Go Masuda (G)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Atsushi Sugimoto (A)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Yuichiro Miki (Y)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Yurie Yamamoto (Y)

Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.
Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.

Tomohiro Sera (T)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Shuhei Kushiyama (S)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Sadaaki Nishimura (S)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Kenji Kuroda (K)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Tomohisa Okuno (T)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Masaichi Ohira (M)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH